Full Text View
Tabular View
No Study Results Posted
Related Studies
The Effect of LY333531 on Protein in the Urine in Patients With Type 2 Diabetes
This study has been completed.
Study NCT00044148   Information provided by Eli Lilly and Company
First Received: August 20, 2002   Last Updated: July 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Urologic Diseases
Interventions listed in this trial
LY333531
Additional drug interventions recognized in this trial
Ruboxistaurin
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services